The conclusion of active breast cancer treatment is often viewed by the medical community as a milestone...
Laily UPN
By Editorial Staff, based on insights from Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information...
Introduction On July 23, 2026, the Department of Health and Human Services (HHS) finalized a sweeping regulatory...
For many patients, the end of active breast cancer treatment—chemotherapy, radiation, or surgery—is not the finish line,...
The biotechnology sector continues to navigate a complex landscape of regulatory scrutiny, clinical trial volatility, and strategic...
By Jonathan Gardner | Published October 8, 2026 In a move designed to fortify its position in...
OTTAWA – New national survey data released by Breast Cancer Canada reveals a profound and growing consensus...
Introduction The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, has concluded a pivotal...
Published October 7, 2026 In the modern era of sedentary work environments and high-stress lifestyles, the human...
In the rapidly shifting landscape of modern medicine, the intersection of patient advocacy, clinical expertise, and genomic...
